Israel–Somaliland Public Health Laboratory Partnership

Health security is the protection of populations from biological threats that can destabilize nations or regions. Unlike traditional security, which centers on military assets and borders, health security addresses the risks posed by pathogens and pandemics, recognizing that disease outbreaks can have economic and social consequences comparable to armed conflict. The World Health Organization and the Global Health Security Agenda emphasize three pillars: preventing outbreaks, rapidly detecting new threats, and mobilizing effective responses. Robust public health laboratories are essential for early detection, rapid testing, and genomic sequencing, enabling swift action to contain outbreaks.

Health security is foundational to societal stability. Failures in this domain can result in significant economic losses, public distrust, and even civil unrest. The “One Health” approach, which links human, animal, and environmental health, is particularly relevant in Somaliland, where close human–livestock interaction increases the risk of zoonotic diseases. Effective health security ensures a healthy workforce, stable governance, and uninterrupted economic activity.

Following Israel’s formal recognition of Somaliland in December 2025, health security has become a central element of bilateral cooperation. Israel’s investment in Somaliland’s public health infrastructure is both a humanitarian and strategic initiative. By supporting stability in Somaliland, Israel secures a reliable partner in the Horn of Africa, particularly near the Bab El-Mandeb strait—a critical maritime corridor. Preventing health crises in Somaliland helps maintain regional stability and counters the influence of other regional actors.

Health initiatives, such as surgical delegations and neonatal care programs, provide tangible benefits to the local population and reinforce diplomatic ties. Somaliland’s challenging environment offers opportunities for Israeli innovation in telehealth, AI diagnostics, solar-powered clinics, and cold-chain storage for vaccines. The partnership also includes the transfer of advanced emergency response models, such as the Magen David Adom system.

Establishing a Somaliland Center for Disease Control (SL-CDC) will enhance disease surveillance and biosecurity, providing real-time data on emerging zoonotic diseases and strengthening the national response to public health threats. Israeli expertise in water purification will help address waterborne diseases, further supporting regional health resilience.

The SL-CDC will serve as the cornerstone of Somaliland’s public health system, improving technical capacity, workforce development, and compliance with international health regulations. It will support programs targeting major health challenges, including infectious and chronic diseases, and foster a cadre of skilled public health professionals.

Strategic Health Goals and Investments:

The establishment of a National Public Health Laboratory (NPHL) in Hargeisa will provide the technical foundation for the SL-CDC, supporting Somaliland’s health policy and reducing reliance on external laboratories. This facility will integrate human and animal health testing, support local innovation, and serve as a regional hub for Israeli diagnostic technologies. It will also enhance early warning capabilities for regional outbreaks and offer a visible, non-militarized benefit to Somaliland, strengthening the bilateral relationship.